Tim-3 signaling pathway as a novel negative mediator in lipopolysaccharide-induced endotoxic shock
Authors:
- 1 May 2014
- journal article
- Published by Elsevier in Human Immunology
- Vol. 75 (5) , 470-478
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tim-3 Expression in Cervical Cancer Promotes Tumor MetastasisPLOS ONE, 2013
- Immune checkpoints in central nervous system autoimmunityImmunological Reviews, 2012
- Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 DiabetesEndocrinology, 2012
- The Pathogenesis of SepsisAnnual Review of Pathology: Mechanisms of Disease, 2011
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunityJournal of Experimental Medicine, 2010
- Galectin-9 Significantly Prolongs the Survival of Fully Mismatched Cardiac Allografts in MiceTransplantation, 2009
- Activation of Tim-3–Galectin-9 pathway improves survival of fully allogeneic skin graftsTransplant Immunology, 2008
- The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graftCellular Immunology, 2007
- The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunityNature Immunology, 2005
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003